RhumbLine Advisers’s Outlook Therapeutics OTLK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,170	Closed	-$19.7K	–	4228
2025 Q1	$19.7K	Sell	16,170 -171,880	-91%	-$301K	﹤0.01%	3741
2024 Q4	$355K	Buy	188,050 +174,896	+1,330%	+$720K	﹤0.01%	2887
2024 Q3	$70.2K	Buy	13,154 +2,563	+24%	+$18.8K	﹤0.01%	3606
2024 Q2	$78.2K	Buy	10,591 +945	+10%	+$7.59K	﹤0.01%	3588
2024 Q1	$115K	Sell	9,646 -46	-0.5%	-$372	﹤0.01%	3396
2023 Q4	$76.4K	Hold	9,692	–	–	﹤0.01%	3530
2023 Q3	$42.8K	Sell	9,692 -24	-0.2%	-$531	﹤0.01%	3679
2023 Q2	$338K	Buy	9,716 +799	+9%	+$21.8K	﹤0.01%	2938
2023 Q1	$194K	Buy	8,917 +1,642	+23%	+$36.7K	﹤0.01%	2743
2022 Q4	$157K	Sell	7,275 -9	-0.1%	-$196	﹤0.01%	2842
2022 Q3	$178K	Buy	7,284 +510	+8%	+$11.9K	﹤0.01%	2921
2022 Q2	$138K	Buy	6,774 +2,142	+46%	+$61.6K	﹤0.01%	3003
2022 Q1	$165K	Buy	4,632 +2,235	+93%	+$69.8K	﹤0.01%	2797
2021 Q4	$65K	Sell	2,397 -103	-4%	-$3.67K	﹤0.01%	2968
2021 Q3	$108K	Buy	2,500 +201	+9%	+$9.7K	﹤0.01%	2985
2021 Q2	$115K	Buy	+2,299	New	+$107K	﹤0.01%	2962